Tumor control of UCARTM1 ∆TGFBR2 showed a trend toward higher efficacy but it was not significant ( P value = 0.07) in this model and, therefore, the benefit of this attribute on its own in this model was not definitive.
← all excerpts
Multi-armored allogeneic MUC1 CAR T cells enhance efficacy and safety in triple-negative breast cancer.
1
—
—